Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products.[ Read More ]
The intrinsic value of one ZBH stock under the base case scenario is HIDDEN Compared to the current market price of 113 USD, Zimmer Biomet Holdings, Inc. is HIDDEN
Current Assets | 4.61 B |
Cash & Short-Term Investments | 416 M |
Receivables | 1.44 B |
Other Current Assets | 2.75 B |
Non-Current Assets | 16.9 B |
Long-Term Investments | 5.4 M |
PP&E | 2.26 B |
Other Non-Current Assets | 14.6 B |
Current Liabilities | 2.86 B |
Accounts Payable | 411 M |
Short-Term Debt | 1.01 B |
Other Current Liabilities | 1.44 B |
Non-Current Liabilities | 6.15 B |
Long-Term Debt | 5.04 B |
Other Non-Current Liabilities | 1.11 B |
Revenue | 7.39 B |
Cost Of Revenue | 2.08 B |
Gross Profit | 5.31 B |
Operating Expenses | 3.28 B |
Operating Income | 1.28 B |
Other Expenses | 254 M |
Net Income | 1.02 B |
Net Income | 1.02 B |
Depreciation & Amortization | 952 M |
Capital Expenditures | -689 M |
Stock-Based Compensation | 99.8 M |
Change in Working Capital | -396 M |
Others | -50 M |
Free Cash Flow | 892 M |
Date | Value | Insider | Amount | Avg Price |
---|---|---|---|---|
5 months ago
May 31, 2024
|
Sell 1.47 M USD
|
Yi Sang
Group President, Asia Pacific |
- 12857
|
114.691 USD |
8 months ago
Mar 07, 2024
|
Sell 216 K USD
|
Yi Sang
Group President, Asia Pacific |
- 1705
|
126.86 USD |
8 months ago
Feb 22, 2024
|
Sell 3.29 M USD
|
Phipps Chad F
Sr. VP/Gen Counsel/Secretary |
- 25546
|
128.6067 USD |
8 months ago
Feb 22, 2024
|
Sell 78.7 K USD
|
Phipps Chad F
Sr. VP/Gen Counsel/Secretary |
- 610
|
129.0807 USD |
1 year ago
Nov 09, 2023
|
Bought 224 K USD
|
Jafry Syed A.
Director |
+ 2135
|
104.75 USD |
1 year ago
Aug 28, 2023
|
Bought 117 K USD
|
BEGLEY CHRISTOPHER B
Director |
+ 1000
|
117.114 USD |
1 year ago
Aug 30, 2023
|
Bought 120 K USD
|
Kolli Sreelakshmi
Director |
+ 1000
|
120.37 USD |
1 year ago
Aug 28, 2023
|
Bought 233 K USD
|
HAGEMANN ROBERT
Director |
+ 2000
|
116.48 USD |
1 year ago
Aug 25, 2023
|
Bought 150 K USD
|
MICHELSON MICHAEL W
Director |
+ 1300
|
115.5 USD |
1 year ago
Aug 25, 2023
|
Bought 100 K USD
|
BERNARD BETSY J
Director |
+ 871
|
114.8364 USD |
6 years ago
Mar 20, 2018
|
Bought 16.8 K USD
|
BERNARD BETSY J
Director |
+ 150
|
111.8867 USD |
1 year ago
Aug 23, 2023
|
Bought 57.3 K USD
|
HIGGINS ARTHUR J
Director |
+ 500
|
114.6751 USD |
1 year ago
Aug 23, 2023
|
Bought 58.3 K USD
|
HIGGINS ARTHUR J
Director |
+ 500
|
116.55 USD |
1 year ago
Mar 17, 2023
|
Sell 2.46 M USD
|
Phipps Chad F
Sr. VP/Gen Counsel/Secretary |
- 19743
|
124.402 USD |
1 year ago
Mar 17, 2023
|
Sell 413 K USD
|
Phipps Chad F
Sr. VP/Gen Counsel/Secretary |
- 3302
|
125.089 USD |
1 year ago
Dec 13, 2022
|
Sell 1.34 M USD
|
Phipps Chad F
Sr. VP/Gen Counsel/Secretary |
- 10459
|
128.5578 USD |
1 year ago
Dec 13, 2022
|
Sell 137 K USD
|
Phipps Chad F
Sr. VP/Gen Counsel/Secretary |
- 1063
|
129.344 USD |
2 years ago
Jul 01, 2022
|
Sell 55.9 K USD
|
VAN ZUILEN WILFRED
Pres, Europe, M. East & Africa |
- 531
|
105.217 USD |
2 years ago
Mar 17, 2022
|
Sell 3.6 M USD
|
Phipps Chad F
Sr. VP/Gen Counsel/Secretary |
- 29518
|
121.8996 USD |
2 years ago
Dec 14, 2021
|
Sell 323 K USD
|
Yi Sang
President, Asia Pacific |
- 2600
|
124.14 USD |
2 years ago
Dec 14, 2021
|
Sell 24.8 K USD
|
Yi Sang
President, Asia Pacific |
- 200
|
124.175 USD |
3 years ago
May 06, 2021
|
Bought 172 K USD
|
HIGGINS ARTHUR J
Director |
+ 1000
|
171.58 USD |
4 years ago
Nov 18, 2020
|
Sell 183 K USD
|
Yi Sang
President, Asia Pacific |
- 1200
|
152.59 USD |
4 years ago
Nov 09, 2020
|
Sell 4.8 M USD
|
Phipps Chad F
Sr. VP/Gen Counsel/Secretary |
- 30040
|
159.7 USD |
4 years ago
May 29, 2020
|
Sell 376 K USD
|
Yi Sang
President, Asia Pacific |
- 3000
|
125.3767 USD |
4 years ago
May 13, 2020
|
Bought 113 K USD
|
Hanson Bryan C
President and CEO |
+ 1000
|
113 USD |